Publications
Publications
Show Results For
- All HBS Web
(120,188)
- Faculty Publications (258)
- November 2012
- Case
Sugar Bowl
By: Richard G. Hamermesh and Alisa Zalosh
Shelby Givens, a recent business school graduate, returned home to Raleigh, North Carolina, to help rescue her family's ailing and outdated bowling alley, Westlake Lanes. Although she cut costs and addressed inefficiencies, moving the business from near-bankruptcy to... View Details
- November 2012
- Supplement
Sugar Bowl, Spreadsheet for Instructors (Brief Case) (CW)
By: Richard G. Hamermesh and Alisa Zalosh
- November 2012
- Supplement
Sugar Bowl, Spreadsheet for Students (Brief Case) (CW)
By: Richard G. Hamermesh and Alisa Zalosh
- November 2012
- Supplement
Amylin Pharmaceuticals (B)
By: Richard G. Hamermesh and Carin-Isabel Knoop
Amylin Pharmaceuticals brought two first-in-class diabetes drugs to market, Byetta and Symlin, in 2005, which were sold in over 80 countries with $650.7 million in sales by 2011. However, the company remained unprofitable as sales plateaued. The small pharmaceutical... View Details
- November 2012 (Revised January 2013)
- Case
Companion Diagnostics: Uncertainties for Approval and Reimbursement
By: Richard G. Hamermesh, Norman C. Selby and Phillip Andrews
The FDA approvals of novel therapeutics were seen as signs in the personalized medicine community of real progress in the growth of personalized medicine. The FDA's approval of such drugs, along with companion diagnostics, suggested a shift in thinking and regulatory... View Details
- September 2012 (Revised September 2012)
- Course Overview Note
Building Life Science Businesses Fall 2012: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Fall 2012 class Building Life Science Businesses View Details
- July 2012 (Revised May 2024)
- Supplement
Lyric Dinner Theater (B)
By: Richard G. Hamermesh and Jim Sharpe
Supplements the (A) Case. Deborah Denenberg reflects on the results and actions taken during the 12 months following her first 6 months on the job. View Details
- July 2012 (Revised May 2024)
- Case
Lyric Dinner Theater (A)
By: Richard G. Hamermesh and Jim Sharpe
Looking back at five years of losses, Rivka Belzer, a newly minted MBA, steps into her family owned business with their mandate to turn it around or close it. In her first six months, she has made a number of changes, with mixed results, but is beginning to show a... View Details
- May 2012
- Case
Westlake Lanes: How Can This Business Be Saved?
By: Richard G. Hamermesh and Alisa Zalosh
Shelby Givens, a new MBA, is the general manager of Westlake Lanes, a near-bankrupt bowling alley that her grandfather founded decades earlier. Givens has been given one year to turn a profit; if the goal is not met Westlake will close. During the first few days on the... View Details
- May 2012
- Teaching Note
Westlake Lanes: How Can This Business Be Saved? (Brief Case)
By: Richard G. Hamermesh and Alisa Zalosh
- May 2012
- Supplement
Westlake Lanes: How Can This Business Be Saved? Spreadsheet for Instructors (Brief Case)
By: Richard G. Hamermesh and Alisa Zalosh
- May 2012
- Supplement
Westlake Lanes: How Can This Business Be Saved? Spreadsheet for Students (Brief Case)
By: Richard G. Hamermesh and Alisa Zalosh
- April 2012
- Case
Meli Marine
By: Richard G. Hamermesh and Sunru Yong
Meli Marine, a container shipping company, is facing an important strategic decision after an interesting acquisition opportunity presents itself. Founded in 1974 by the Chang Family, the Singapore-based company has carved out a niche in the intra-Asia transport... View Details
- April 2012
- Supplement
Meli Marine, Instructor Supplement (Brief Case)
By: Richard G. Hamermesh and Sunru Yong
- April 2012
- Supplement
Meli Marine, Spreadsheet Supplement (Brief Case)
By: Richard G. Hamermesh and Sunru Yong
- March 2012 (Revised October 2013)
- Supplement
Gene Patents (B)
By: Richard Hamermesh and Phillip Andrews
The case updates events since the Court's ruling against Myriad Genetics on March 29, 2010 and should be used in conjunction with Gene Patents (A). On July 29, 2011, a US Appeals Court reversed the prior ruling against Myriad. On September 16, 2011, the first major... View Details
Keywords: Courts and Trials; Patents; Genetics; Judgments; Investment; Biotechnology Industry; United States
- October 2011 (Revised December 2012)
- Case
eHealthpoint: Healthcare for Rural India
By: Richard G. Hamermesh, Mona Sinha and Elizabeth Vrolyk
Healthpoint Services sought to address rural India's shortage of quality and affordable healthcare with a multi-service platform that comprised telemedical health clinics called eHealthpoints, clean drinking water, a diagnostic lab, and a pharmacy. Could they convince... View Details
- October 2011
- Case
Gene Sequencing: Staking a Position in an Expanding Industry
By: Richard G. Hamermesh, Mara Aspinall and Phillip Andrews
Towards the end of 2010, companies in the gene sequencing industry were pushing aggressive R&D programs to develop technologies and products in the race to sequence the entire human genome at a cost of $1,000. It remained to be seen when the "$1,000 genome" would... View Details